Mai A Abd El Fattah
Overview
Explore the profile of Mai A Abd El Fattah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Al-Kishali H, Abd El Fattah M, Mohammad W, El-Abhar H
JGH Open
. 2019 Aug;
3(4):281-289.
PMID: 31406920
Background: Inflammatory bowel diseases are immunologically mediated disorders of gastrointestinal tract, characterized by dysregulated immune responses that result in a chronic intestinal inflammation. The antiplatelet cilostazol (CS), a phosphodiesterase-III inhibitor,...
12.
Badawi G, Abd El Fattah M, Zaki H, El Sayed M
Neurotox Res
. 2019 Jan;
35(3):635-653.
PMID: 30673988
L-dopa is still considered as the gold standard therapy for Parkinson's disease (PD); however, L-dopa-induced dyskinesia (LID) is a serious complication of long-term L-dopa treatment. The present study investigated the...
13.
El-Abhar H, Abd El Fattah M, Wadie W, El-Tanbouly D
PLoS One
. 2018 Sep;
13(9):e0203837.
PMID: 30260985
Countless neurodegenerative diseases are associated with perverse multiple targets of cyclic nucleotide signalling, hastening neuronal death. Cilostazol, a phosphodiesterase-III inhibitor, exerts neuroprotective effects against sundry models of neurotoxicity, however, its...
14.
Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice
Azmy S, Abd El Fattah M, Abd El-Rahman S, Nada S, Abdel Salam O, El-Yamany M, et al.
Neurotoxicology
. 2018 Jun;
67:245-258.
PMID: 29906478
Nicotine and tramadol concomitant drug dependence pose increasing social, economic as well as public threats. Accordingly, the present study investigated neurochemical, neurobehavioral and neuropathological changes in the brain subsequent to...
15.
Rabie M, Abd El Fattah M, Nassar N, El-Abhar H, Abdallah D
Biochem Pharmacol
. 2018 Feb;
151:126-134.
PMID: 29428223
MAS receptor (MASR), expressed in several brain areas, conferred neuroprotection against neurodegenerative disorders when activated by angiotensin (Ang) 1-7; however, its role in Parkinson's disease (PD) remains elusive. Intra-striatal post-administration...
16.
Kandil E, Sayed R, Ahmed L, Abd El Fattah M, El-Sayeh B
Mol Neurobiol
. 2017 Jun;
55(5):4078-4089.
PMID: 28585189
Recently, it has been shown that both decreased nuclear receptor-related 1 (Nurr1) expression and thrombin accumulation are involved in the degeneration of dopaminergic neurons in Parkinson's disease (PD). The new...
17.
Badawi G, Abd El Fattah M, Zaki H, El Sayed M
Inflammopharmacology
. 2017 Mar;
25(3):369-382.
PMID: 28258522
The present study investigated the possible relationship between pro-inflammatory cytokines and programmed nigral neuronal death in rotenone model of Parkinson's disease (PD). Sitagliptin and liraglutide efficacy to inhibit the inflammatory-apoptotic...
18.
Shibrya E, Radwan R, Abd El Fattah M, Shabaan E, Kenawy S
Int J Radiat Biol
. 2017 Jan;
93(5):553-560.
PMID: 28067097
Objective: Fibromyalgia is a prevalent disorder characterized by chronic widespread pain and complex symptoms. This study was conducted to investigate the potential therapeutic effect of low-dose irradiation (LDI) alone or...
19.
Alhumaidha K, Saleh D, Abd El Fattah M, El-Eraky W, Moawad H
Can J Physiol Pharmacol
. 2015 Dec;
94(2):131-139.
PMID: 26695545
Cyclophosphamide (CP) is a cytotoxic alkylating agent used in the treatment of malignant diseases and autoimmune disorders. Its clinical use is limited to its marked cardiorenal toxicity. The present study...